New Zealand's Ebos To Buy Aussie Wholesaler From Hong Kong Owner
This article was originally published in PharmAsia News
Executive Summary
Ebos Group plans to acquire Australia drug wholesaler Symbion for $700 million from Hong Kong's Zuellig Group in exchange for a 40% stake in the New Zealand drug maker.